Cargando…
Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
SIMPLE SUMMARY: Ovarian clear cell carcinoma (OCCC) has a poor prognosis in advanced cases and displays resistance to standard treatments for epithelial ovarian cancer. OCCC shows a specific clinical characteristic of a high incidence of cancer-associated thromboembolism. In this review, we focused...
Autores principales: | Tamura, Ryo, Yoshihara, Kosuke, Enomoto, Takayuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099459/ https://www.ncbi.nlm.nih.gov/pubmed/35565252 http://dx.doi.org/10.3390/cancers14092125 |
Ejemplares similares
-
How Does Endometriosis Lead to Ovarian Cancer? The Molecular Mechanism of Endometriosis-Associated Ovarian Cancer Development
por: Yachida, Nozomi, et al.
Publicado: (2021) -
Clonal lineage from normal endometrium to ovarian clear cell carcinoma through ovarian endometriosis
por: Suda, Kazuaki, et al.
Publicado: (2020) -
Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma
por: Tamura, Ryo, et al.
Publicado: (2023) -
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
por: Shoji, Tadahiro, et al.
Publicado: (2021) -
Therapeutic strategies in epithelial ovarian cancer
por: Kim, Ayako, et al.
Publicado: (2012)